MYH9 and neoplasm: Elevated stiffness, nevertheless, suppresses tumor immunogenicity by activating the Rho-associated coiled-coil kinase-non-muscle myosin heavy chain IIA-filamentous actin pathway in tumor cells, which inhibits cGAS-STING pathway activation and consequently reduces DC differentiation 9.